Congenital anemia from fetal blood loss
ICD-10 P61.3 is a billable code used to indicate a diagnosis of congenital anemia from fetal blood loss.
Congenital anemia from fetal blood loss is a condition characterized by a decrease in red blood cell mass due to blood loss that occurs in utero. This can result from various factors, including placental abruption, twin-to-twin transfusion syndrome, or maternal hemorrhage. The condition can lead to significant morbidity in neonates, including hypoxia, organ dysfunction, and increased risk of neonatal intensive care unit (NICU) admission. Diagnosis is typically made through clinical evaluation, laboratory tests showing low hemoglobin levels, and imaging studies to assess for underlying causes of fetal blood loss. Management may involve intrauterine transfusions, postnatal transfusions, and supportive care in the NICU. Early recognition and intervention are crucial to improving outcomes for affected infants.
Detailed records of hemoglobin levels, transfusion history, and clinical assessments.
Neonates presenting with pallor, lethargy, or respiratory distress requiring NICU admission.
Accurate coding requires understanding of the underlying causes of anemia and associated complications.
Comprehensive history and physical examination notes, including maternal health history.
Pediatric follow-up for infants with a history of congenital anemia, monitoring growth and development.
Consideration of long-term outcomes and potential developmental delays in affected infants.
Used when a newborn with P61.3 requires blood transfusions due to severe anemia.
Document the indication for transfusion, type of blood product, and patient response.
Neonatologists must ensure compliance with transfusion protocols and monitor for adverse reactions.
Common causes include maternal hemorrhage, placental abruption, and twin-to-twin transfusion syndrome. Each of these conditions can lead to significant fetal blood loss, resulting in anemia.
